Literature DB >> 11085958

Expression of platelet-activating factor receptor in human carotid atherosclerotic plaques: relevance to progression of atherosclerosis.

I Brochériou1, D Stengel, L Mattsson-Hultén, J Stankova, M Rola-Pleszczynski, F Koskas, O Wiklund, Y Le Charpentier, E Ninio.   

Abstract

BACKGROUND: Human monocyte-derived macrophages synthesize numerous proinflammatory and prothrombotic substances, including lipid mediators, such as platelet-activating factor (PAF), which may play a major role in the onset and perpetuation of atherosclerotic lesions. In addition, both monocytes and macrophages express PAF receptors (PAF-R). The expression of PAF-R is transcriptionally downregulated by oxidized LDL in in vitro primary cultures of monocyte/macrophages. In this study, we evaluated the expression of PAF-R in human carotid plaque tissue, in foam cells isolated from human carotid plaques, and in primary cultures of umbilical smooth muscle cells (SMCs). METHODS AND
RESULTS: We show that PAF-R was expressed at low levels in foam cells compared with monocyte/macrophages in plaques, as assessed by immunohistochemical staining and in situ hybridization. In addition, low levels of mRNA were also detected by RT-PCR in isolated human carotid foam cells. A prominent finding of our study was the demonstration that contractile SMCs were positive for PAF-R, and its mRNA was extracted from primary cultures of umbilical SMCs.
CONCLUSIONS: As macrophages loose their inflammatory phenotype on transformation into foam cells, they may equally loose their capacity of defense against aggression. We postulate that the diminished expression of PAF-R may be deleterious in the context of plaque formation and progression. The observation that arterial SMCs of contractile phenotype express PAF-R opens new avenues concerning the migration of these cells from media to intima and atherosclerotic plaque formation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11085958     DOI: 10.1161/01.cir.102.21.2569

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

1.  Platelet-activating factor increases VE-cadherin tyrosine phosphorylation in mouse endothelial cells and its association with the PtdIns3'-kinase.

Authors:  Hélène Hudry-Clergeon; Dominique Stengel; Ewa Ninio; Isabelle Vilgrain
Journal:  FASEB J       Date:  2005-04       Impact factor: 5.191

2.  Identification of differential protein expression associated with development of unstable human carotid plaques.

Authors:  Mark Slevin; Abdul Baset Elasbali; Marta Miguel Turu; Jerzy Krupinski; Lina Badimon; John Gaffney
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

3.  Rescue of internalization-defective platelet-activating factor receptor function by EBP50/NHERF1.

Authors:  Denis J Dupré; Marek Rola-Pleszczynski; Jana Stankova
Journal:  J Cell Commun Signal       Date:  2012-08-10       Impact factor: 5.782

4.  Oxidized low-density lipoprotein and peroxisome-proliferator-activated receptor alpha down-regulate platelet-activating-factor receptor expression in human macrophages.

Authors:  D Hourton; P Delerive; J Stankova; B Staels; M J Chapman; E Ninio
Journal:  Biochem J       Date:  2001-02-15       Impact factor: 3.857

5.  Co-stimulation of PAFR and CD36 is required for oxLDL-induced human macrophages activation.

Authors:  Francisco J O Rios; Mariana M Koga; Matheus Ferracini; Sonia Jancar
Journal:  PLoS One       Date:  2012-05-03       Impact factor: 3.240

6.  Hydroxyl-platelet-activating factor exists in blood of healthy volunteers and periodontal patients.

Authors:  Smaragdi Antonopoulou; Alexandros Tsoupras; George Baltas; Helen Kotsifaki; Zacharias Mantzavinos; Constantinos A Demopoulos
Journal:  Mediators Inflamm       Date:  2003-08       Impact factor: 4.711

7.  Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary artery.

Authors:  Demokritos C Tsoukatos; Isabelle Brochériou; Vassilios Moussis; Christina P Panopoulou; Elena D Christofidou; Stamatis Koussissis; Socratis Sismanidis; Ewa Ninio; Stavros Siminelakis
Journal:  J Lipid Res       Date:  2008-06-27       Impact factor: 5.922

8.  Uptake of oxLDL and IL-10 production by macrophages requires PAFR and CD36 recruitment into the same lipid rafts.

Authors:  Francisco J O Rios; Matheus Ferracini; Mateus Pecenin; Marianna M Koga; Yajuan Wang; Daniel F J Ketelhuth; S Jancar
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.